e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Benefit of treatment of latent tuberculosis infection in individual patients
Fluegge Kyle
Source:
Eur Respir J 2016; 47:1592-1594
Journal Issue:
May
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fluegge Kyle. Benefit of treatment of latent tuberculosis infection in individual patients. Eur Respir J 2016; 47:1592-1594
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Tuberculosis in renal transplant recipients on isoniazid prophylaxis
Diagnosis of Latent TB Infection: the role of IGRAs
Related content which might interest you:
Outcomes of treatment of latent tuberculosis infection in children with two different regimens
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006
Completion of treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005
Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
A choice of regimen improves completion for patients with latent TB infection
Source: Breathe 2008; 4: 366
Year: 2008
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
Treatment of latent infection with Mycobacterium tuberculosis: update 2010
Source: Eur Respir J 2011; 37: 690-711
Year: 2011
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016
Latent tuberculosis infection in a drug treatment centre
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002
Diagnosing and treatment of latent tuberculosis infction in children
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
Source: Eur Respir J 2016; 47:1492-1501
Year: 2016
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
How should we treat latent tuberculosis infection?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept